![Andreas Muehler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 537 244 $ al 31/05/2026
Andreas Muehler is the founder of Immunic AG, founded in 2016, serving as Chief Medical Officer since its founding.
Dr. Muehler is currently Managing Director at Xanomed GmbH.
Former jobs include President & Chief Executive Officer at MicroMRI, Inc. from 2008 to 2010; Chief Executive Officer & VP-Corporate Development at Cellectar, Inc.; Managing Director at STRIVE Healthcare GmbH; Chief Medical Officer at Immunic, Inc. from 2016 to 2026; Chief Medical Officer at Vital Therapies, Inc.; and President at CAD Sciences LLC.
Education includes an MBA from Duke University and a doctorate from Humboldt-Universität zu Berlin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMUNIC, INC. 0,26 % | 26/05/2026 | 35.912 ( 0,26 % ) | 537 244 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals in the immunology space | Fundador | 01/04/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
| IMMUNIC, INC. | Director Técnico/Científico/I+D | 24/04/2026 |
CAD Sciences LLC
 CAD Sciences LLC Packaged SoftwareTechnology Services Develops computer-assisted visualization of contrast enhancement in MR imaging of cancer | Presidente | 01/01/2006 |
Cellectar, Inc.
 Cellectar, Inc. Miscellaneous Commercial ServicesCommercial Services Develops radiopharmaceuticals products to detect, treat and monitor human cancers | Director Ejecutivo | - |
STRIVE Healthcare GmbH
 STRIVE Healthcare GmbH Financial ConglomeratesFinance Invests in the healthcare sector | Director Ejecutivo | - |
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
MicroMRI, Inc.
 MicroMRI, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops medical devices | Electronic Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectar, Inc.
Cellectar, Inc. Miscellaneous Commercial ServicesCommercial Services Develops radiopharmaceuticals products to detect, treat and monitor human cancers | Commercial Services |
CAD Sciences LLC
CAD Sciences LLC Packaged SoftwareTechnology Services Develops computer-assisted visualization of contrast enhancement in MR imaging of cancer | Technology Services |
STRIVE Healthcare GmbH
STRIVE Healthcare GmbH Financial ConglomeratesFinance Invests in the healthcare sector | Finance |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals in the immunology space | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
